I am a biomedical researcher passionate about understanding and curing human viral diseases, with a primary focus on HIV/AIDS. I have over 16 years of experience in HIV virology, immunology, pathogenesis, and cure strategies, including immune therapies and vaccine development. My laboratory at Emory University investigates HIV and SIV infection dynamics in T cell progenitors and thymic regenerative mechanisms, with the overarching goal of developing an effective HIV cure strategy.
My research program is supported by two CFAR Developmental Awards and an NIH R21 grant (FAIN# R21OD035572), which collectively advance our understanding of the cellular HIV reservoir during antiretroviral therapy and the role of hematopoietic progenitors in shaping antiviral immunity. In addition to HIV, I have leveraged my expertise to design and evaluate novel vaccine candidates against other major human viruses, including SARS-CoV-2 and HCV. I am committed to conducting rigorous, translational research in highly collaborative environments using organoids and in vivo models to bridge fundamental discoveries with therapeutic applications.
Throughout my career, I have been fortunate to receive several recognitions for scientific excellence, including the NIH Fellows Award for Research Excellence (2016), the AIDS Vaccine Award (2019), and the CROI Young Investigator Award (2021). I also take great pride in mentoring students and postdoctoral fellows, fostering their scientific growth and curiosity.
I am a biomedical researcher passionate about understanding and curing human viral diseases, with a primary focus on HIV/AIDS. I have over 16 years of experience in HIV virology, immunology, pathogenesis, and cure strategies, including immune therapies and vaccine development. My laboratory at Emory University investigates HIV and SIV infection dynamics in T cell progenitors and thymic regenerative mechanisms, with the overarching goal of developing an effective HIV cure strategy.
My research program is supported by two CFAR Developmental Awards and an NIH R21 grant (FAIN# R21OD035572), which collectively advance our understanding of the cellular HIV reservoir during antiretroviral therapy and the role of hematopoietic progenitors in shaping antiviral immunity. In addition to HIV, I have leveraged my expertise to design and evaluate novel vaccine candidates against other major human viruses, including SARS-CoV-2 and HCV. I am committed to conducting rigorous, translational research in highly collaborative environments using organoids and in vivo models to bridge fundamental discoveries with therapeutic applications.
Throughout my career, I have been fortunate to receive several recognitions for scientific excellence, including the NIH Fellows Award for Research Excellence (2016), the AIDS Vaccine Award (2019), and the CROI Young Investigator Award (2021). I also take great pride in mentoring students and postdoctoral fellows, fostering their scientific growth and curiosity.